ALX Oncology Investor Relations
Investor Relations
Replay available
ALX Oncology Holdings Inc. (ALXO) Q4 2025 Earnings Call
ALX Oncology Holdings Inc. (NASDAQ: ALXO) Q4 2025 earnings conference call, held 2026-02-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jason Letman
Chief Executive Officer
Dr. Barb Klinke
Chief Medical Officer
Harish Antharam
Chief Financial Officer
Alison Brassel
Analyst, Piper Sandler
Sam Slutsky
Analyst, Lifestyle Capital
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Alx Oncology Holdings Inc..
Replay transcript excerpt
WEBVTT 00:00:00.166 -- 00:00:05.432 and welcome to the ALX Oncology fourth quarter 2025 financial 00:00:05.432 -- 00:00:10.758 results call and webcast. At this time, all participants are in a listen-only mode. 00:00:10.758 -- 00:00:14.282 A question and answer session will follow the formal presentation. 00:00:14.282 -- 00:00:17.865 If anyone should require upwards or assistance during the conference, please press star 00:00:17.865 -- 00:00:22.230 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:22.230 -- 00:00:27.977 I would now like to turn the call over to your host, Jason Letman, Chief Executive Officer. 00:00:27.977 -- 00:00:30.878 Thank you. You may begin. 00:00:31.638 -- 00:00:36.947 Thank you, and welcome to our Q4 and fiscal year 2025 00:00:36.947 -- 00:00:37.729 results call. 00:00:37.729 -- 00:00:41.134 Appreciate you all spending some time with us this morning. 00:00:41.134 -- 00:00:45.662 As usual, we will be making forward-looking statements during the call, so please refer 00:00:45.662 -- 00:00:51.092 to our FOS slide in our corporate deck. With me today, we have 00:00:51.092 -- 00:00:55.660 Harish Antharam, our CFO, as well as our CMO, Dr. 00:00:55.660 -- 00:01:00.507 Barb Klinke. And in terms of the first bit of news, we're delighted to announce today 00:01:00.507 -- 00:01:05.732 that Barb will continue leading our clinical efforts as our permanent chief medical 00:01:05.732 -- 00:01:07.994 officer. Welcome, Barb. 00:01:07.994 -- 00:01:14.240 As many of you know, after joining in an interim capacity in September 2025, 00:01:14.240 -- 00:01:18.524 Barb has been absolutely instrumental in driving our development programs forward over 00:01:18.524 -- 00:01:23.589 the last five months. Barb, as many of you also know...